2024
-
Experts to explore controversies around omission of axillary staging in ER-positive breast cancer
Monica Morrow, MD, will moderate a session looking at evolving practices around axillary staging in estrogen receptor-positive breast cancer and implications on adjuvant therapies.
-
Immunotherapy panel discussion to explore inroads for ER-positive disease, challenges ahead
Heather McArthur, MD, MPH, will guide a Thursday afternoon panel discussion about how immunotherapy may expand its reach and the tools physicians can use to make therapeutic selections.
-
SABCS Snippets: Risk-reducing surgeries and survival in young BRCA carriers
Matteo Lambertini, MD, PhD, associate professor at the University of Genova – IRCCS, talks with Marcela Mazo Canola, MD, about the association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer.
-
SABCS Snippets: Results from the Breast Cancer Weight Loss (BWEL) Trial
Jennifer A. Ligibel, MD, senior physician in the Breast Oncology Center at Dana-Farber Cancer Institute, Boston, Massachusetts, talks with Lindsay L. Peterson, MD, MSCR, about results from the Breast Cancer Weight Loss (BWEL) Trial, which tested the efficacy of a weight loss intervention on metabolic and inflammatory biomarkers in women with obesity and breast cancer.
-
SABCS Snippets: SHR-A1811 in the Neoadjuvant Treatment of HER2-positive Early Breast Cancer
Junjie Li, MD, associate chief physician at Fudan University Shanghai Cancer Center, Shanghai, China, talks with Saba Shaikh, MD, about the HER2-directed antibody-drug conjugate SHR-A1811 in the neoadjuvant treatment of HER2-positive early breast cancer.
-
People’s Choice session to explore past, present, and future of ADCs in breast cancer
Paolo Tarantino, MD, will moderate a People’s Choice educational session on future directions in antibody-drug conjugates on Wednesday afternoon.
-
SABCS® Daily Highlights for Wednesday, December 11
Plan your Wednesday schedule and don’t miss notable items on the program, including the first General Session, the keynote address from a Nobel Prize winner, and the 2024 William L. McGuire Memorial Lecture.
-
AACR to honor trailblazing breast cancer researchers during the 2024 SABCS®
Christina Curtis, PhD, MSc, left, and Steffi Oesterreich, PhD, will be recognized by the American Association for Cancer Research (AACR) for significant contributions to breast cancer research.
-
State of the Art session to explore role of immune biomarkers in the early-stage setting
Sherene Loi, MBBS (Hons), PhD, FRACP, FAHMS, GAICD, will lead a panel discussion on Wednesday afternoon about the winding road of immune biomarkers in early breast cancer.
-
Panelists to weigh benefits of early detection against mortality risks, quality of life
Ismail Jatoi, MD, PhD, will moderate a Wednesday afternoon risk reduction and early detection session on updates in breast cancer screening.